|
VERASTEM, Inc. (VSTM) DCF Valoración
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Verastem, Inc. (VSTM) Bundle
¡Mejore sus estrategias de inversión con la calculadora DCF de Verastem, Inc. (VSTM)! Utilice los datos financieros reales de Verastem, ajuste las predicciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de Verastem, Inc. (VSTM).
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 17.5 | 88.5 | 2.1 | 2.6 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 407.08 | -97.68 | 26.45 | -100 | -17.81 | -17.81 | -17.81 | -17.81 | -17.81 |
EBITDA | -126.6 | -50.4 | -61.0 | -71.6 | -83.2 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | -725.27 | -56.95 | -2972.33 | -2756.43 | 100 | -51.39 | -51.39 | -51.39 | -51.39 | -51.39 |
Depreciation | 2.0 | 1.3 | .2 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 11.45 | 1.5 | 10.03 | 4.55 | 100 | 25.5 | 25.5 | 25.5 | 25.5 | 25.5 |
EBIT | -128.6 | -51.7 | -61.2 | -71.7 | -83.2 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | -736.72 | -58.45 | -2982.37 | -2760.98 | 100 | -51.69 | -51.69 | -51.69 | -51.69 | -51.69 |
Total Cash | 75.5 | 141.2 | 100.3 | 87.9 | 137.1 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 2.5 | .2 | .5 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 14.46 | 0.27001 | 25.13 | 1.19 | 100 | 28.21 | 28.21 | 28.21 | 28.21 | 28.21 |
Inventories | 3.1 | .0 | -100.8 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 17.74 | 0 | -4908.52 | 0 | 100 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 |
Accounts Payable | 9.7 | 1.9 | 2.3 | 4.9 | 7.2 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 55.31 | 2.12 | 112.13 | 188.79 | 100 | 71.49 | 71.49 | 71.49 | 71.49 | 71.49 |
Capital Expenditure | .0 | .0 | -.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | -0.04010082 | -0.0372814 | -9.55 | 0 | 100 | -1.92 | -1.92 | -1.92 | -1.92 | -1.92 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -145.8 | -51.9 | -69.7 | -71.7 | -83.2 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -139.8 | -53.0 | 31.2 | -169.3 | -80.8 | -7.2 | .0 | .0 | .0 | .0 |
WACC, % | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 |
PV UFCF | ||||||||||
SUM PV UFCF | -6.7 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | -7 | |||||||||
Net Debt | -36 | |||||||||
Equity Value | 30 | |||||||||
Diluted Shares Outstanding, MM | 22 | |||||||||
Equity Value Per Share | 1.34 |
What You Will Get
- Real VSTM Financial Data: Pre-filled with Verastem’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Verastem’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Real-Life VSTM Data: Pre-filled with Verastem’s historical financials and forward-looking projections.
- Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
- Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
- User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.
How It Works
- Step 1: Download the prebuilt Excel template with Verastem's data included.
- Step 2: Explore the pre-filled sheets and understand the key metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including Verastem's intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose This Calculator for Verastem, Inc. (VSTM)?
- Accuracy: Utilizes real Verastem financial data to ensure precision.
- Flexibility: Allows users to easily test and adjust inputs as needed.
- Time-Saving: Eliminate the need to create a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.
Who Should Use This Product?
- Investors: Accurately estimate Verastem, Inc.'s (VSTM) fair value before making investment decisions.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to Verastem, Inc. (VSTM).
- Consultants: Quickly adapt the template for valuation reports specific to Verastem, Inc. (VSTM) for clients.
- Entrepreneurs: Gain insights into financial modeling practices employed by companies like Verastem, Inc. (VSTM).
- Educators: Use it as a teaching tool to demonstrate valuation methodologies relevant to Verastem, Inc. (VSTM).
What the Template Contains
- Historical Data: Includes Verastem, Inc.'s (VSTM) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Verastem, Inc.'s (VSTM) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Verastem, Inc.'s (VSTM) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.